Also trades as: TLT.V (TSXV) · $vol 0M
TLTFF OTC
Theralase Technologies Inc.
1W: +1.2%
1M: -7.6%
3M: -35.3%
YTD: -5.0%
1Y: -8.2%
3Y: -21.7%
5Y: -30.4%
$0.13
+0.00 (+0.28%)
Weekly Expected Move ±5.1%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+18.3% ▲
Capital Expenditures
$20K
+46.4% ▲
5Y CAGR: -48.2%
Free Cash Flow
-$3M
+18.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$225K
+115.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$4M | -$5M | -$5M | -$4M |
| Depreciation & Amort. | $272K | $276K | $313K | $286K | $272K |
| Stock-Based Comp. | $912K | $318K | $192K | $621K | $521K |
| Change in Working Capital | -$50K | -$238K | -$422K | -$436K | $103K |
| Other Non-Cash Items | $18K | $24K | $49K | $26K | $34K |
| Operating Cash Flow | -$4M | -$4M | -$5M | -$4M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$165K | -$101K | -$70K | -$37K | -$20K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$165K | -$101K | -$70K | -$37K | -$20K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$52K | -$57K | -$76K | -$117K | -$117K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$5K | -$750 | $344K | -$750 | -$2K |
| Financing Cash Flow | -$58K | -$57K | $3M | $3M | $4M |
| Net Change in Cash | -$5M | -$4M | -$2M | -$1M | $225K |
| Cash End of Period | $8M | $4M | $2M | $44K | $269K |
| Free Cash Flow | -$5M | -$4M | -$5M | -$4M | -$3M |